Hey there! Welcome!
Get updated on
Select Speciality
Top Picks
5 Feb, 24SCCM 2024
Key session presented at the Critical Care Congress held on 21-23 January, 2024, at Phoenix, Arizona.
14 Feb, 24
16 Mar, 24Arthritis Res Ther.
In a recent meta-analysis, the prevalence of sarcopenia in spondyloarthritis (SpA) patients was found to be significant, with an overall prevalence of 25.0%. Notably, presarcopenia and severe sarcopenia were observed at rates of 21.0% and 8.7%, respectively. These findings underscored the need for targeted interventions to prevent and manage sarcopenia in this patient group.
15 Mar, 24Diabetes Res Clin Pr...
Despite similar durations of diabetes, youth with T2D experienced significantly higher incidences of major adverse events compared to their T1D counterparts. T2D individuals exhibited 2.5-fold higher microvascular, 4.0-fold higher macrovascular, and 2.7-fold higher gastrointestinal disease rates. Risk factors such as age at diagnosis, HbA1c, gender, mean arterial pressure (MAP), and BMI played significant roles.
14 Mar, 24Clin. Infect. Dis.
- Completing the full TB preventive therapy (TPT) regimen resulted in a significantly lower TB incidence rate (1.1/1000 PY) compared to those who didn't finish (2.9/1000 PY; IRR= 2.7)
- Risk of TB was higher within 28 months after starting TPT (3.5/1000 PY) compared to the period between 28 and 143 months (1.1/1000 PY) suggesting a waning but persistent protective effect of TPT over time
14 Mar, 24Diabetes Res Clin Pr...
- Intensive treatment reduced risk of microvascular complications in T2DM patients, but the same increased in those with high HbA1c variability
- Standard treatment increased the risk in those with lower HbA1c variability (except nephropathy)
- For instance, in those with lowest HbA1c variability intensive treatment reduced the retinopathy risk by 35%, but increased it by 28% in those with higher HbA1c variability
Featured
19 Apr, 23
24 Apr, 23
13 Jan, 22